+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07597512

Association Between Changes in Urinary Chloride and Sodium and Residual Fluid Overload in Acute Heart Failure Hospitalization

Led by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Updated on 2026-09-28

223

Participants Needed

4

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating how changes in urinary sodium and chloride levels relate to fluid overload and short-term outcomes in patients hospitalized with acute heart failure AHF. The study aims to determine if these changes reflect how effectively excess fluid is removed during hospital stays and whether they are linked to congestion at discharge and the risk of worsening heart failure or death afterward. This prospective, multicenter observational study plans to enroll at least 223 patients with AHF treated with intravenous diuretics. Participants hospitalized for AHF and receiving intravenous diuretics as part of their usual care will undergo multiple clinical assessments, blood and urine tests, and echocardiographic evaluations during their hospital stay. Researchers will collect biochemical and echocardiographic data, including biomarkers such as NT-proBNP, CA125, sST2, bioADM, and CD146. Clinical events like worsening heart failure and all-cause mortality will be tracked at 30 days and 3 months after discharge. Decongestion will be assessed using clinical evaluations, echographic parameters, and estimated plasma volume status. Throughout the study, participants will have repeated tests and assessments during hospitalization to monitor fluid status and heart function. Researchers will measure residual congestion 72 hours after admission and follow participants for clinical outcomes for up to three months after discharge. The study focuses on evaluating how urinary sodium and chloride dynamics relate to patient outcomes in AHF without interfering with standard treatments, lasting from hospital admission through three months post-discharge.

CONDITIONS

Brief Title

Urinary Chloride and Sodium Changes and Residual Congestion in Acute Heart Failure

Research Team

P

Pau Llàcer Iborra, MD PhD

C

Cristina Fernández Soler

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here